Vaccine Design and Testing – Products

ACROBiosystems offers premium antigens (pre-fusion F, post-fusion F, glycoprotein G) and a Monoclonal Anti-Nipah Antibody for accurate ELISA-based evaluation and vaccine potency studies, supporting Nipah and Hendra virus research.

This interview explores expert insights into cutting-edge methodologies that overcome these challenges, providing actionable insights to optimize vaccine safety and efficacy.

Unlock actionable insights with i-Ome™ Discovery, an advanced platform for biomarker research. With precision and reliability, uncover targetable biomarkers: disease-associated proteins, pathogenic antibodies, and protective antibodies.

This application note explores the cutting-edge tools that allow researchers to efficiently assess the integrity and purity of IVT mRNA, ensuring high-quality results.

Thermo Fisher Scientific has introduced the Invitrogen Vivofectamine™ Delivery Solutions to provide high-performance lipid nanoparticles (LNP) technology for non-viral delivery of nucleic acids.

Transgene and ProBioGen, announce that the companies have entered into a license agreement for ProBioGen’s AGE1.CR.pIX® suspension cell line.

This article explores how mRNA and VLP vaccines represent a significant advancement in vaccine technology and will play a role in protection against infectious diseases.

This whitepaper evaluates the results of a study into the three main capping options available to manufacturers, highlighting expert insights on mRNA capping costs and customer needs.

This application note outlines best practices for handling and analyzing IVT mRNA, ensuring accurate assessments of mRNA sizing, resolution and percent purity.

Sino Biological is at the forefront of accelerating Mpox research, offering a comprehensive portfolio of MPXV proteins and antibodies.